Treatment for the Mental Health Impact of Killing in War

Completed

• Conditions: Posttraumatic Stress Disorder (PTSD)

• Registration Number: NCT01406834
• Lead Sponsor: University of California, San Francisco

Brief Summary

The goal of this project is to test the feasibility, acceptability, and efficacy of a treatment module addressing the mental health and functional impact of killing in the war zone.

The investigators will enroll between 12-20 Veterans who have killed in war and have been diagnosed with post-traumatic stress disorder (PTSD) for a pilot study assessing the efficacy of the six-session treatment. Veterans will be randomized either to the treatment or to the waitlist control group.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2011-07-19
• Study First Submitted QC: 2011-07-28
• Study First Posted: 2011-08-01
• Study Start: 2011-10
• Primary Completion: 2013-06
• Study Completion: 2013-06
• Status Verified: 2014-08
• Last Update Submitted: 2014-08-14
• Last Update Posted: 2014-08-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 8

Inclusion Criteria

• Diagnosis of PTSD
• Veteran will need to endorse having taken another life in a war zone context
• Have received some prior evidence-based treatment for PTSD

Read More

Exclusion Criteria

• Meet current or lifetime criteria for a psychotic disorder
• Participants in current PTSD treatment will not be excluded;however,if receiving medications they will need to be stabilized on current medications for at least one month.
• If receiving Prolonged Exposure Therapy or Cognitive Behavioral Therapy, individuals will need to wait two weeks after they have completed the treatment to enroll in the study.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in psychological symptoms as measured by the Symptom Checklist-90 (SCL-90-R)	Measured at baseline and study completion (week 7)	A brief multidimensional self-report inventory that screens for nine symptoms of psychopathology and provides three global distress indicators.

Secondary Outcome Measures

Name	Time	Method
Change in killing-related maladaptive cognitions as measured by the Killing Cognitions Scale (KCS)	Measured at baseline and study completion (week 7)	Assesses killing-related maladaptive cognitions

Trial Locations

Locations (1)

San Francisco VA Medical Center; 🇺🇸 San Francisco, California, United States